Notification of trade primary insider

CSO of Biotec Pharmacon, Dr. Rolf E. Engstad, has
today purchased 50,000 shares in the Company at an
average price of NOK 4.09 per share.
Dr. Engstad holds 111,133 shares after this
transaction.